NCT04061525

Brief Summary

The concept of the "ischemic cascade" is generally accepted hypothesis, according to which whenever ischemia of the myocardium occurs there is a consequence of events, that always occur in a given order - diastolic dysfunction first, followed by systolic dysfunction, then changes on electrocardiogram (ECG) and finally chest pain sensation. The occurrence of every next stage of cascade means more severe ischemia and respectively - more severe myocardial damage. We propose that mechanical and electrical changes in the myocardium during ischemia appear simultaneously.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 19, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

August 19, 2019

Status Verified

August 1, 2019

Enrollment Period

2.9 years

First QC Date

August 15, 2019

Last Update Submit

August 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Side branch region ischemia

    Beginning, duration, sequence of the electric, kinetic and haemodynamic signs of ischemia, comparison between ischemic cascade and constellation.

    Percutaneous coronary intervention procedure time (up to 4 hours)

Secondary Outcomes (4)

  • Target lesion revascularization

    12 months

  • Number of patients not alive

    12 months

  • Myocardial infarction after hospital discharge

    12 months

  • New onset angina or heart failure symptoms

    12 months

Other Outcomes (1)

  • Periprocedural myonecrosis - extent of post PCI enzyme elevation

    48 hours

Study Arms (1)

Patients with coronary bifurcation lesions

Patients from 18 to 90-years old with coronary bifurcation lesions with significant \>50% diameter stenosis artery scheduled for intervention of the main vessel (Medina types: 1x1, x11, 111)

Procedure: Percutaneous coronary intervention with FFR measurement and intracoronary ECG registration

Interventions

Measurement of fractional flow reserve (FFR), registration of intracoronary ECG and radioscopic registration of wire tip movement in the main and in the side branch in the beginning, at the end and during every step of coronary bifurcation percutaneous intervention.

Patients with coronary bifurcation lesions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* Significant, \>50% diameter stenosis artery scheduled for intervention of the main vessel (Medina types: 1x1, x11, 111); * Side branch vessel at least 2.0 mm

You may qualify if:

  • Subject at least 18 years of age.
  • Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
  • Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
  • Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.

You may not qualify if:

  • Subjects with significant ST-T change (≥ 1mm).
  • Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
  • Subjects who refuse to give informed consent.
  • Subjects with the following angiographic characteristics: left main coronary artery stenosis, total occlusion before occurrence of SB, lesion of interest located at infarct-related artery.
  • Subjects with LVEF \< 30%.
  • Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy.
  • LBBB, RBBB, atrial fibrillation/flutter with no identifiable isoelectric line.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandrovska University Hospital

Sofia, Bulgaria

RECRUITING

Related Publications (1)

  • Vassilev DI, Mileva NB, Yaneva-Sirakova T, Georgiev RS, Kassab G. Validation of Coronary Wire for the Acquisition of Intracoronary Electrocardiogram in Swine. Catheter Cardiovasc Interv. 2025 Nov;106(5):3030-3033. doi: 10.1002/ccd.70145. Epub 2025 Sep 7.

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Dobrin Vassilev

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dobrin Vassilev

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 15, 2019

First Posted

August 19, 2019

Study Start

February 1, 2019

Primary Completion

January 1, 2022

Study Completion

January 1, 2024

Last Updated

August 19, 2019

Record last verified: 2019-08

Locations